Global Transmucosal Drug Delivery Market 2017 Demand, Insights, Key Players, Segmentation and Forecast to 2022

Published On: Aug 2017

Format: PDF

Publisher: QY Research

Pages: 120

Report ID: 105727

Notes:
Sales, means the sales volume of Transmucosal Drug Delivery
Revenue, means the sales value of Transmucosal Drug Delivery

This report studies sales (consumption) of Transmucosal Drug Delivery in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
3M Pharmaceuticals
Acrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences, Inc
Aveva Drug Delivery Systems
Corium International, Inc
DURECT Corporation
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
MedPharm LTD
Mylan, Inc.
Nemaura Pharma Ltd
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
Tesa Labtec GmbH
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Transmucosal Drug Delivery in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Passive Transdermal Drug Delivery
Active Transdermal Drug Delivery
Split by applications, this report focuses on sales, market share and growth rate of Transmucosal Drug Delivery in each application, can be divided into
Aqueous solutions
Lozenges
Gels
Others

Table of Contents

Global Transmucosal Drug Delivery Sales Market Report 2017
1 Transmucosal Drug Delivery Overview
1.1 Product Overview and Scope of Transmucosal Drug Delivery
1.2 Classification of Transmucosal Drug Delivery
1.2.1 Passive Transdermal Drug Delivery
1.2.2 Active Transdermal Drug Delivery
1.3 Application of Transmucosal Drug Delivery
1.3.1 Aqueous solutions
1.3.2 Lozenges
1.3.3 Gels
1.3.4 Others
1.4 Transmucosal Drug Delivery Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Transmucosal Drug Delivery (2012-2022)
1.5.1 Global Transmucosal Drug Delivery Sales and Growth Rate (2012-2022)
1.5.2 Global Transmucosal Drug Delivery Revenue and Growth Rate (2012-2022)

2 Global Transmucosal Drug Delivery Competition by Manufacturers, Type and Application
2.1 Global Transmucosal Drug Delivery Market Competition by Manufacturers
2.1.1 Global Transmucosal Drug Delivery Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Transmucosal Drug Delivery Revenue and Share by Manufacturers (2012-2017)
2.2 Global Transmucosal Drug Delivery (Volume and Value) by Type
2.2.1 Global Transmucosal Drug Delivery Sales and Market Share by Type (2012-2017)
2.2.2 Global Transmucosal Drug Delivery Revenue and Market Share by Type (2012-2017)
2.3 Global Transmucosal Drug Delivery (Volume and Value) by Regions
2.3.1 Global Transmucosal Drug Delivery Sales and Market Share by Regions (2012-2017)
2.3.2 Global Transmucosal Drug Delivery Revenue and Market Share by Regions (2012-2017)
2.4 Global Transmucosal Drug Delivery (Volume) by Application

3 United States Transmucosal Drug Delivery (Volume, Value and Sales Price)
3.1 United States Transmucosal Drug Delivery Sales and Value (2012-2017)
3.1.1 United States Transmucosal Drug Delivery Sales and Growth Rate (2012-2017)
3.1.2 United States Transmucosal Drug Delivery Revenue and Growth Rate (2012-2017)
3.1.3 United States Transmucosal Drug Delivery Sales Price Trend (2012-2017)
3.2 United States Transmucosal Drug Delivery Sales and Market Share by Manufacturers
3.3 United States Transmucosal Drug Delivery Sales and Market Share by Type
3.4 United States Transmucosal Drug Delivery Sales and Market Share by Application

4 China Transmucosal Drug Delivery (Volume, Value and Sales Price)
4.1 China Transmucosal Drug Delivery Sales and Value (2012-2017)
4.1.1 China Transmucosal Drug Delivery Sales and Growth Rate (2012-2017)
4.1.2 China Transmucosal Drug Delivery Revenue and Growth Rate (2012-2017)
4.1.3 China Transmucosal Drug Delivery Sales Price Trend (2012-2017)
4.2 China Transmucosal Drug Delivery Sales and Market Share by Manufacturers
4.3 China Transmucosal Drug Delivery Sales and Market Share by Type
4.4 China Transmucosal Drug Delivery Sales and Market Share by Application

5 Europe Transmucosal Drug Delivery (Volume, Value and Sales Price)
5.1 Europe Transmucosal Drug Delivery Sales and Value (2012-2017)
5.1.1 Europe Transmucosal Drug Delivery Sales and Growth Rate (2012-2017)
5.1.2 Europe Transmucosal Drug Delivery Revenue and Growth Rate (2012-2017)
5.1.3 Europe Transmucosal Drug Delivery Sales Price Trend (2012-2017)
5.2 Europe Transmucosal Drug Delivery Sales and Market Share by Manufacturers
5.3 Europe Transmucosal Drug Delivery Sales and Market Share by Type
5.4 Europe Transmucosal Drug Delivery Sales and Market Share by Application

6 Japan Transmucosal Drug Delivery (Volume, Value and Sales Price)
6.1 Japan Transmucosal Drug Delivery Sales and Value (2012-2017)
6.1.1 Japan Transmucosal Drug Delivery Sales and Growth Rate (2012-2017)
6.1.2 Japan Transmucosal Drug Delivery Revenue and Growth Rate (2012-2017)
6.1.3 Japan Transmucosal Drug Delivery Sales Price Trend (2012-2017)
6.2 Japan Transmucosal Drug Delivery Sales and Market Share by Manufacturers
6.3 Japan Transmucosal Drug Delivery Sales and Market Share by Type
6.4 Japan Transmucosal Drug Delivery Sales and Market Share by Application
7 Southeast Asia Transmucosal Drug Delivery (Volume, Value and Sales Price)
7.1 Southeast Asia Transmucosal Drug Delivery Sales and Value (2012-2017)
7.1.1 Southeast Asia Transmucosal Drug Delivery Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Transmucosal Drug Delivery Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Transmucosal Drug Delivery Sales Price Trend (2012-2017)
7.2 Southeast Asia Transmucosal Drug Delivery Sales and Market Share by Manufacturers
7.3 Southeast Asia Transmucosal Drug Delivery Sales and Market Share by Type
7.4 Southeast Asia Transmucosal Drug Delivery Sales and Market Share by Application
8 India Transmucosal Drug Delivery (Volume, Value and Sales Price)
8.1 India Transmucosal Drug Delivery Sales and Value (2012-2017)
8.1.1 India Transmucosal Drug Delivery Sales and Growth Rate (2012-2017)
8.1.2 India Transmucosal Drug Delivery Revenue and Growth Rate (2012-2017)
8.1.3 India Transmucosal Drug Delivery Sales Price Trend (2012-2017)
8.2 India Transmucosal Drug Delivery Sales and Market Share by Manufacturers
8.3 India Transmucosal Drug Delivery Sales and Market Share by Type
8.4 India Transmucosal Drug Delivery Sales and Market Share by Application

9 Global Transmucosal Drug Delivery Manufacturers Analysis
9.1 3M Pharmaceuticals
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Transmucosal Drug Delivery Product Type, Application and Specification
9.1.2.1 Passive Transdermal Drug Delivery
9.1.2.2 Active Transdermal Drug Delivery
9.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Acrux Limited
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Transmucosal Drug Delivery Product Type, Application and Specification
9.2.2.1 Passive Transdermal Drug Delivery
9.2.2.2 Active Transdermal Drug Delivery
9.2.3 Acrux Limited Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 ALZA Corporation
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Transmucosal Drug Delivery Product Type, Application and Specification
9.3.2.1 Passive Transdermal Drug Delivery
9.3.2.2 Active Transdermal Drug Delivery
9.3.3 ALZA Corporation Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Antares Pharma, Inc.
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Transmucosal Drug Delivery Product Type, Application and Specification
9.4.2.1 Passive Transdermal Drug Delivery
9.4.2.2 Active Transdermal Drug Delivery
9.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Apricus BioSciences, Inc
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Transmucosal Drug Delivery Product Type, Application and Specification
9.5.2.1 Passive Transdermal Drug Delivery
9.5.2.2 Active Transdermal Drug Delivery
9.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Aveva Drug Delivery Systems
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Transmucosal Drug Delivery Product Type, Application and Specification
9.6.2.1 Passive Transdermal Drug Delivery
9.6.2.2 Active Transdermal Drug Delivery
9.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Corium International, Inc
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Transmucosal Drug Delivery Product Type, Application and Specification
9.7.2.1 Passive Transdermal Drug Delivery
9.7.2.2 Active Transdermal Drug Delivery
9.7.3 Corium International, Inc Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 DURECT Corporation
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Transmucosal Drug Delivery Product Type, Application and Specification
9.8.2.1 Passive Transdermal Drug Delivery
9.8.2.2 Active Transdermal Drug Delivery
9.8.3 DURECT Corporation Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Generex Biotechnology Corporation
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Transmucosal Drug Delivery Product Type, Application and Specification
9.9.2.1 Passive Transdermal Drug Delivery
9.9.2.2 Active Transdermal Drug Delivery
9.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Inovio Pharmaceuticals, Inc.
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Transmucosal Drug Delivery Product Type, Application and Specification
9.10.2.1 Passive Transdermal Drug Delivery
9.10.2.2 Active Transdermal Drug Delivery
9.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
9.12 MedPharm LTD
9.13 Mylan, Inc.
9.14 Nemaura Pharma Ltd
9.15 Nitto Denko Corporation
9.16 Noven Pharmaceuticals, Inc.
9.17 Pantec Biosolutions AG
9.18 Tapemark
9.19 Tesa Labtec GmbH
9.20 TEVA Pharmaceutical Industries Ltd.
9.21 Zosano Pharma

10 Transmucosal Drug Delivery Maufacturing Cost Analysis
10.1 Transmucosal Drug Delivery Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Transmucosal Drug Delivery
10.3 Manufacturing Process Analysis of Transmucosal Drug Delivery

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Transmucosal Drug Delivery Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Transmucosal Drug Delivery Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Transmucosal Drug Delivery Market Forecast (2017-2022)
14.1 Global Transmucosal Drug Delivery Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Transmucosal Drug Delivery Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Transmucosal Drug Delivery Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Transmucosal Drug Delivery Price and Trend Forecast (2017-2022)
14.2 Global Transmucosal Drug Delivery Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Transmucosal Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Transmucosal Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Transmucosal Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Transmucosal Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Transmucosal Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Transmucosal Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Transmucosal Drug Delivery Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Transmucosal Drug Delivery Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source